Results 211 to 220 of about 13,813 (247)
Craspedocephalus trigonocephalus Envenomation in the United States: A Case Report. [PDF]
Gartner HT +4 more
europepmc +1 more source
Characterization of Alpha-Bungarotoxin Antibodies Prepared by Different Strategies. [PDF]
Lu H +6 more
europepmc +1 more source
Evaluation of Nanodiamond-in-Oil Emulsion with Snake Venom to Enhance Potent Antibody Induction in Mice and Rabbits. [PDF]
Lin MH +5 more
europepmc +1 more source
Geographic Variation in Venom Proteome and Toxicity Profiles of Chinese <i>Naja atra</i>: Implications for Antivenom Optimization. [PDF]
Zhao J, Shi X, Liu G, Yang Y, Huang C.
europepmc +1 more source
Strokes following snakebite envenomations: A systematic review and individual patient data meta-analysis. [PDF]
Almeida T +12 more
europepmc +1 more source
Successful Management of Intravascular Hemolysis Caused by Systemic Loxoscelism With Antivenom: A Case Report. [PDF]
Guadarrama-Fernández C +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Record, 2014
WE would like to invite veterinary practitioners to take part in a clinical trial of Europe's first dedicated veterinary snake antivenom, ViperaVet. This is directed against the venom of four medically important Vipera species found throughout western Europe, including the adder ( Vipera berus) , Britain's only native venomous snake. Between September
Fiona, Bolton +2 more
openaire +2 more sources
WE would like to invite veterinary practitioners to take part in a clinical trial of Europe's first dedicated veterinary snake antivenom, ViperaVet. This is directed against the venom of four medically important Vipera species found throughout western Europe, including the adder ( Vipera berus) , Britain's only native venomous snake. Between September
Fiona, Bolton +2 more
openaire +2 more sources
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2013
The first advance on crude filtered immune serum or plasma for treating systemically envenomed bite victims was the use of IgG (predominantly equine) precipitated by salt treatment. This was followed by the development of F(ab')(2) antivenoms, prepared using pepsin digestion to remove both the highly reactive and nonspecific Fc part of the IgG molecule
R D, Theakston, D C, Smith
openaire +1 more source
The first advance on crude filtered immune serum or plasma for treating systemically envenomed bite victims was the use of IgG (predominantly equine) precipitated by salt treatment. This was followed by the development of F(ab')(2) antivenoms, prepared using pepsin digestion to remove both the highly reactive and nonspecific Fc part of the IgG molecule
R D, Theakston, D C, Smith
openaire +1 more source

